XML 21 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK COMPENSATION PLANS (Details Textual) (USD $)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended 1 Months Ended 3 Months Ended 9 Months Ended 1 Months Ended 3 Months Ended
Aug. 31, 2013
Feb. 28, 2013
Aug. 31, 2012
May 31, 2013
Aug. 31, 2013
Aug. 31, 2012
Nov. 30, 2012
Aug. 31, 2013
Xenogenics Corporation [Member]
Aug. 31, 2012
Xenogenics Corporation [Member]
Aug. 31, 2013
Xenogenics Corporation [Member]
Aug. 31, 2012
Xenogenics Corporation [Member]
Feb. 03, 2011
Xenogenics Corporation [Member]
Oct. 31, 2010
Xenogenics Corporation [Member]
Nov. 30, 2010
Executive Officer [Member]
Xenogenics Corporation [Member]
Mar. 31, 2011
Officers and Members of Scientific Advisory Board [Member]
Xenogenics Corporation [Member]
Feb. 29, 2012
Officers and Members of Scientific Advisory Board [Member]
Xenogenics Corporation [Member]
Aug. 31, 2013
Director [Member]
Aug. 31, 2012
Director [Member]
Aug. 31, 2013
Employee [Member]
Aug. 31, 2012
Employee [Member]
Jul. 28, 2013
Consultant [Member]
Feb. 29, 2012
Replacement Options [Member]
Aug. 31, 2013
Equity Incentive Plan 2004 [Member]
Dec. 02, 2012
Equity Incentive Plan 2004 [Member]
Dec. 02, 2011
Equity Incentive Plan 2004 [Member]
Jul. 11, 2011
Equity Incentive Plan 2004 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized                       8,000,000 5,000,000                     1,500,000 1,500,000 70,974,213
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant                                             22,074,710      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross         30,000,000                 2,500,000 3,000,000   5,000,000 1,000,000 5,000,000 1,000,000 500,000 1,250,000        
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price         $ 0.0011                 $ 0.246 $ 0.246   $ 0.0011 $ 0.0032 $ 0.0011 $ 0.0032 $ 0.246 $ 0.253        
Share-based Compensation Arrangement by Share-based Payment Award, Award Term                             5 years   5 years 5 years 5 years 5 years 5 years 5 years        
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date                           Nov. 30, 2015                        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Granted in Period Fair Value                           $ 576,250 $ 692,700           $ 117,000 $ 298,500        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value         $ 0.0011 $ 0.0030               $ 0.2305 $ 0.2309           $ 0.234 $ 0.2338        
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate   1.89%   2.16% 2.78%   1.62%             1.23% 2.20%   1.60% 0.62%     1.37% 0.84%        
Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate   147.00%   148.00% 148.00%   141.00%             165.00% 165.00%   175.00% 170.00%     175.00% 170.00%        
Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Term   10 years   10 years 10 years   10 years             5 years 5 years   5 years 5 years     5 years 5 years        
Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate   0.00%   0.00% 0.00%   0.00%             0.00% 0.00%   0.00% 0.00%     0.00% 0.00%        
Share-based Compensation, Total 52,945   105,446   175,866 226,162         251,128                              
Reversal Allocated Share-based Compensation Expense                     57,725         57,725                    
Allocated Share-based Compensation Expense 1,893   9,521   10,705 32,759   51,052 95,925 165,161 193,403                              
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Stock Options 35,000       35,000     83,000   83,000                                
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition         1 year 4 months 24 days         6 months                                
Closing Price Share $ 0.0012       $ 0.0012                                          
Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Number                           500,000                        
Share Based Compensation Arrangement By Share Based Payment Award Option Vested And Expected To Vest Outstanding Number                           2,000,000                        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Percentage                             50.00%                      
Stock Issuance Qualified Financing Milestone for Proceeds                             $ 5,000,000                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period                             1,500,000                      
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent                   100.00%                                
Share-based Compensation Arrangement by Share-based Payment Award, Original Terms of Plan                   10% stockholder shall not be granted an ISO unless the exercise price of such option is at least 110% of the fair market value of Xenogenics’ common stock on the date of the grants and the option is not exercisable after the expiration of five years from the date of the grant.                                
Share-based Compensation Arrangement by Share-based Payment Award, Option, Maximum Term                   10 years